This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Mwamburi M, Macalino G, Wilson I, Mitty J, Griffith J, Neuman P, Wanke C, Flanigan T, Wong J.Cost-effectiveness analysis of modified directly observed therapy for HAART for patients with poor adherence in the adherence to antiretroviral therapy for substance abusers trial. 16th International AIDS Conference - Volume 1: 340, 13 Aug 2006
Mwamburi M, Macalino G, Griffith J, Mitty J, Wilson I, Neuman P, Wanke C, Flanigan T, Wong J.Immediate versus delayed modified directly observed HAART therapy: a cost-effectiveness analysis from the adherence to antiretroviral therapy for substance abusers study. 16th International AIDS Conference - Volume 1 (Suppl.): 282-283, 13 Aug 2006
Rights and permissions
About this article
Cite this article
MDOT a good choice for poor HAART adherence. Pharmacoecon. Outcomes News 514, 6 (2006). https://doi.org/10.2165/00151234-200605140-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200605140-00011